1. Home
  2. EVC vs CATX Comparison

EVC vs CATX Comparison

Compare EVC & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

N/A

Current Price

$8.61

Market Cap

335.0M

Sector

Industrials

ML Signal

N/A

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

N/A

Current Price

$2.81

Market Cap

355.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVC
CATX
Founded
1996
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.0M
355.0M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
EVC
CATX
Price
$8.61
$2.81
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$12.11
AVG Volume (30 Days)
1.2M
980.0K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
5.35%
N/A
EPS Growth
47.59
N/A
EPS
0.32
N/A
Revenue
$536,034,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$26.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.95
$1.96
52 Week High
$13.74
$6.16

Technical Indicators

Market Signals
Indicator
EVC
CATX
Relative Strength Index (RSI) 43.70 35.35
Support Level $7.72 $2.25
Resistance Level $10.09 $2.96
Average True Range (ATR) 0.36 0.16
MACD 0.13 -0.04
Stochastic Oscillator 88.37 4.38

Price Performance

Historical Comparison
EVC
CATX

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: